Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
Johns Hopkins University · Johns Hopkins Medicine
Abstract
The immune-modulating effects of radiotherapy (XRT) have gained considerable interest recently, and there have been multiple reports of synergy between XRT and immunotherapy. However, additional preclinical studies are needed to demonstrate the antigen-specific nature of radiation-induced immune responses and elucidate potential mechanisms of synergy with immunotherapy. Here, we demonstrate the ability of stereotactic XRT to induce endogenous antigen-specific immune responses when it is combined with anti-PD-1 checkpoint blockade immunotherapy. Using the small animal radiation research platform (SARRP), image-guided stereotactic XRT delivered to B16-OVA melanoma or 4T1-HA breast carcinoma tumors resulted in…
Citation impact
- FWCI
- 16.41
- Percentile
- 100%
- References
- 58
Authors
8- ABAndrew B. Sharabi
Johns Hopkins University, Johns Hopkins Medicine
- CJChristopher J. Nirschl
Johns Hopkins University, Johns Hopkins Medicine
- CMChristina M. Kochel
Johns Hopkins University, Johns Hopkins Medicine
- TRThomas R. Nirschl
Johns Hopkins University, Johns Hopkins Medicine
- BJBrian J. Francica
Johns Hopkins University, Johns Hopkins Medicine
Topics & keywords
- Immune system
- Antigen
- Immunotherapy
- Cancer research
- Immunology
- Medicine
- T cell
- Antigen presentation
- Good health and well-being